These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31686408)

  • 21. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence.
    Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P
    Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure.
    Pourcyrous M; Elabiad MT; Rana D; Gaston KP; DeBaer L; Dhanireddy R
    Pediatr Res; 2021 Aug; 90(2):459-463. PubMed ID: 33214673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical care of neonates undergoing opioid withdrawal in the immediate postpartum period.
    Oji-Mmuo CN; Jones AN; Wu EY; Speer RR; Palmer T
    Neurotoxicol Teratol; 2021; 86():106978. PubMed ID: 33838247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential problems and solutions of opioid-based treatment in neonatal opioid withdrawal syndrome (NOWS): a scoping review protocol.
    Mills-Huffnagle S; Nyland JE
    BMJ Open; 2023 Feb; 13(2):e067883. PubMed ID: 36806065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal opioid use disorder and infant mortality in Wisconsin, United States, 2010-2018.
    Mallinson DC; Kuo HD; Kirby RS; Wang Y; Berger LM; Ehrenthal DB
    Prev Med; 2024 Apr; 181():107914. PubMed ID: 38408650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
    Gersch H; Shah D; Chroust A; Bailey B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics.
    van Hoogdalem MW; McPhail BT; Hahn D; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):87-103. PubMed ID: 33049155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome.
    Townsel C; Covault JM; Hussain N; Oncken C; Nold C; Campbell WA
    J Matern Fetal Neonatal Med; 2021 Mar; 34(5):670-676. PubMed ID: 31092079
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of
    Bailey BA; Shah DS; Boynewicz KL; Justice NA; Wood DL
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9383-9390. PubMed ID: 35109759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome.
    Jones HE; Kraft WK
    Clin Perinatol; 2019 Jun; 46(2):349-366. PubMed ID: 31010564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice.
    Borrelli KN; Wingfield KK; Yao EJ; Zamorano CA; Sena KD; Beierle JA; Roos MA; Zhang H; Wachman EM; Bryant CD
    Neuropharmacology; 2023 Dec; 240():109732. PubMed ID: 37774943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
    Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome.
    Radhakrishna U; Vishweswaraiah S; Uppala LV; Szymanska M; Macknis J; Kumar S; Saleem-Rasheed F; Aydas B; Forray A; Muvvala SB; Mishra NK; Guda C; Carey DJ; Metpally RP; Crist RC; Berrettini WH; Bahado-Singh RO
    Genomics; 2021 May; 113(3):1127-1135. PubMed ID: 33711455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An epidemiological examination of neonatal opioid withdrawal syndrome and maternal and infant characteristics.
    Schwartz AN; Meschke LL
    Arch Womens Ment Health; 2024 Oct; 27(5):863-867. PubMed ID: 38573341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.
    Velez ML; Jordan CJ; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107020. PubMed ID: 34419619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
    Velez ML; Jordan C; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
    Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
    J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome.
    Kuzniewicz MW; Campbell CI; Li S; Walsh EM; Croen LA; Comer SD; Pimentel SD; Hedderson M; Sun LS
    J Perinatol; 2023 Mar; 43(3):293-299. PubMed ID: 36131095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding barriers to timely identification of infants at risk of neonatal opiate withdrawal syndrome.
    Howell MP; Smith AM; Lindsay EB; Drury SS
    J Matern Fetal Neonatal Med; 2021 Apr; 34(7):1161-1166. PubMed ID: 31195865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.
    Tang F; Ng CM; Bada HS; Leggas M
    Clin Transl Sci; 2021 Jul; 14(4):1231-1249. PubMed ID: 33650314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.